Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition

Molecular Biology Reports

Volumn 41, Issue 7, 2014, Pages 4507-4512

  Zong, Huajie ^a   Yin, Baobing ^a   Zhou, Huading ^a   Cai, Duan ^a   Ma, Baojin ^a   Xiang, Yang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

EMT; Gallbladder cancer; mTOR; TGF

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN; CADHERIN; IMMUNOSUPPRESSIVE AGENT; MULTIPROTEIN COMPLEX; SMALL INTERFERING RNA; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOGENESIS; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GALLBLADDER CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MIGRATION INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR INVASION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; DRUG EFFECTS; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, NUDE; MULTIPROTEIN COMPLEXES; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

EID: 84903379888     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3321-4     Document Type: Article

References (19)

1. Gourgiotis S et al (2008) Gallbladder cancer. Am J Surg 196:252-264 (Pubitemid 351970506)
2. Leal P et al (2013) Immunohistochemical expression of phosphomTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma. Arch Pathol Lab Med 137:552-557
3. de Aretxabala XA et al (1997) Curative resection in potentially resectable tumours of the gallbladder. Eur J Surg 163:419-426
4. de Aretxabala XA et al (2004) Laparoscopic cholecystectomy: its effect on the prognosis of patients with gallbladder cancer. World J Surg 28:544-547
5. Abahssain H et al (2010) Chemotherapy in gallbladder carcinoma. Presse Med 39:1238-1245
6. de Aretxabala X et al (2004) Neoadjuvant chemoradiotherapy in gallbladder cancer. Rev Med Chil 132:51-57
7. Rudi J (2002) Chemotherapy with gemcitabine in patients with gall-bladder carcinoma. Ann Oncol 13:807
8. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428
9. Yun SJ, Kim WJ (2013) Role of the epithelial-mesenchymal transition in bladder cancer: from prognosis to therapeutic target. Korean J Urol 54:645-650
10. Leal P et al (2013) AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines. Onco Targets Ther 6:1373-1384
11. Wu Q et al (2007) Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model. Cancer Res 67:3794-3800 (Pubitemid 46762166)
12. Ding G et al (2013) Combination of rapamycin, CI-1040, and 17-AAG inhibits metastatic capacity of prostate cancer via Slug inhibition. PLoS ONE 8:e77400
13. Mikaelian I et al (2013) Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-beta-independent mechanism. Cancer Res 73:6621-6631
14. Wen H et al (2013) Med19 promotes bone metastasis and invasiveness of bladder urothelial carcinoma via bone morphogenetic protein 2. Ann Diagn Pathol 17:259-264
15. Gulhati P et al (2011) mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res 71:3246-3256
16. Liu L et al (2006) Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Oncogene 25:7029-7040 (Pubitemid 44722071)
17. Jacinto E et al (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6:1122-1128 (Pubitemid 39468014)
18. Moss SC, Lightell DJ Jr, Marx SO, Marks AR, Woods TC (2010) Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1. J Biol Chem 285:11991-11997
19. Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R (2012) TGF-beta-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci 125:1259-1273